REVIVA PHARMACEUTCLS HLDGS I's ticker is RVPH and the CUSIP is 76152G100. A total of 25 filers reported holding REVIVA PHARMACEUTCLS HLDGS I in Q4 2022. The put-call ratio across all filers is 0.52 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $153,012 | -3.7% | 31,355 | +15.6% | 0.00% | – |
| Q2 2023 | $158,894 | +39.9% | 27,115 | 0.0% | 0.00% | – |
| Q1 2023 | $113,612 | -14.5% | 27,115 | -13.2% | 0.00% | – |
| Q4 2022 | $132,825 | +681.3% | 31,253 | +195.3% | 0.00% | – |
| Q3 2022 | $17,000 | +41.7% | 10,584 | 0.0% | 0.00% | – |
| Q2 2022 | $12,000 | -53.8% | 10,584 | 0.0% | 0.00% | – |
| Q1 2022 | $26,000 | -16.1% | 10,584 | 0.0% | 0.00% | – |
| Q4 2021 | $31,000 | -27.9% | 10,584 | 0.0% | 0.00% | – |
| Q3 2021 | $43,000 | -15.7% | 10,584 | 0.0% | 0.00% | – |
| Q2 2021 | $51,000 | – | 10,584 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 1,200,000 | $5,832,000 | 1.16% |
| EMC Capital Management | 75,835 | $257,000 | 0.15% |
| ARMISTICE CAPITAL, LLC | 714,700 | $3,473,000 | 0.06% |
| Tower Research Capital LLC (TRC) | 12,484 | $61,000 | 0.00% |
| UBS Group AG | 2,033 | $10,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 34 | $0 | 0.00% |
| NORTHERN TRUST CORP | 10,584 | $51,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 67,724 | $329,000 | 0.00% |
| Renaissance Technologies | 11,250 | $55,000 | 0.00% |